Researchers in Japan have developed a predictive model that could improve treatment decisions for advanced pancreatic cancer ...

The Tumor Marker Gene Model (TMGM) is a diagnostic tool to determine if patients with pancreatic cancer are suited for post-treatment surgery. It determines how a patient’s DNA affects their ...

A new gene therapy reversed heart failure in pigs by repairing heart function through cBIN1, showing major promise for future ...

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...

The new "Tumor Marker Gene Model" (TMGM) addresses this limitation by including genetic information when making a prognosis. The model assesses the patient's genotype-the complete set of genetic ...

The model demonstrates robustness and generalizability, offering a cost-effective alternative to traditional experimental methods for optimizing gene therapy vectors. This summary was ...